Aldosterone inhibition and coronary endothelial function in women without obstructive coronary artery disease: An ancillary study of the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation

American Heart Journal

Volumn 167, Issue 6, 2014, Pages 826-832

  Bavry, Anthony A ^a   Handberg, Eileen M ^a   Huo, Tianyao ^a   Lerman, Amir ^b   Quyyumi, Arshed A ^c   Shufelt, Chrisandra ^d   Sharaf, Barry ^e   Merz, C Noel Bairey ^d   Cooper Dehoff, Rhonda M ^a,f   Sopko, George ^g   Pepine, Carl J ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CEDARS SINAI MEDICAL CENTER   (United States)

^e RHODE ISLAND HOSPITAL   (United States)

^f UNIVERSITY OF FLORIDA HEALTH   (United States)

^g NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ADENOSINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPLERENONE; POTASSIUM;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD FLOW VELOCITY; BLOOD VESSEL DIAMETER; BODY MASS; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY SPASM; CORONARY ENDOTHELIAL DYSFUNCTION; CORONARY FLOW RESERVE; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; DRUG TOLERABILITY; ENDOTHELIAL DYSFUNCTION; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; MULTICENTER STUDY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEATTLE ANGINA QUESTIONNAIRE; SYSTOLIC BLOOD PRESSURE;

ACETYLCHOLINE; ADULT; AGED; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIAC CATHETERIZATION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VESSELS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MIDDLE AGED; MINERALOCORTICOID RECEPTOR ANTAGONISTS; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE (U.S.); SPIRONOLACTONE; TREATMENT OUTCOME; UNITED STATES; VASODILATION; VASODILATOR AGENTS;

EID: 84901777950     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2014.01.017     Document Type: Article

References (36)

1. B. Lagerqvist, K. Safstrom, and E. Stahle et al. Is early invasive treatment of unstable coronary artery disease equally effective for both women and men? FRISC II Study Group Investigators J Am Coll Cardiol 38 2001 41 48 (Pubitemid 32613826)
2. R. Glaser, H.C. Herrmann, and S.A. Murphy et al. Benefit of an early invasive management strategy in women with acute coronary syndromes JAMA 288 2002 3124 3129 (Pubitemid 36014129)
3. T.C. Clayton, S.J. Pocock, and R.A. Henderson et al. Do men benefit more than women from an interventional strategy in patients with unstable angina or non-ST-elevation myocardial infarction? The impact of gender in the RITA 3 trial Eur Heart J 25 2004 1641 1650 (Pubitemid 39209285)
4. L. Jespersen, A. Hvelplund, and S.Z. Abildstrom et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events Eur Heart J 33 2012 734 744
5. L.J. Shaw, C.N. Merz, and C.J. Pepine et al. The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation Circulation 114 2006 894 904 (Pubitemid 44337132)
6. M. Gulati, R.M. Cooper-DeHoff, and C. McClure et al. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project Arch Intern Med 169 2009 843 850
7. C.J. Pepine, R.D. Anderson, and B.L. Sharaf et al. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study J Am Coll Cardiol 55 2010 2825 2832
8. G.O. von Mering, C.B. Arant, and T.R. Wessel et al. Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) Circulation 109 2004 722 725 (Pubitemid 38222890)
9. J.P. Halcox, W.H. Schenke, and G. Zalos et al. Prognostic value of coronary vascular endothelial dysfunction Circulation 106 2002 653 658 (Pubitemid 34851922)
10. Y. Shahin, J.A. Khan, and N. Samuel et al. Angiotensin converting enzyme inhibitors effect on endothelial dysfunction: a meta-analysis of randomised controlled trials Atherosclerosis 216 2011 7 16
11. D.F. Pauly, B.D. Johnson, and R.D. Anderson et al. In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: a double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE) Am Heart J 162 2011 678 684
12. G. Fujisawa, K. Okada, and S. Muto et al. Spironolactone prevents early renal injury in streptozotocin-induced diabetic rats Kidney Int 66 2004 1493 1502 (Pubitemid 39298382)
13. Y.S. Kang, G.J. Ko, and M.H. Lee et al. Effect of eplerenone, enalapril and their combination treatment on diabetic nephropathy in type II diabetic rats Nephrol Dial Transplant 24 2009 73 84
14. H. Trachtman, A.C. Weiser, and E. Valderrama et al. Prevention of renal fibrosis by spironolactone in mice with complete unilateral ureteral obstruction J Urol 172 2004 1590 1594 (Pubitemid 39244992)
15. V.M. Campese, and J. Park Use of antagonists of aldosterone in patients with chronic kidney disease: potential advantages and risks J Hypertens 24 2006 2157 2159 (Pubitemid 44611022)
16. M. Epstein, G.H. Williams, and M. Weinberger et al. Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes Clin J Am Soc Nephrol 1 2006 940 951
17. A. Sato, K. Hayashi, and M. Naruse et al. Effectiveness of aldosterone blockade in patients with diabetic nephropathy Hypertension 41 2003 64 68 (Pubitemid 36056793)
18. M. Epstein Aldosterone as a mediator of progressive renal disease: pathogenetic and clinical implications Am J Kidney Dis 37 2001 677 688 (Pubitemid 32273153)
19. K.J. Schjoedt The renin-angiotensin-aldosterone system and its blockade in diabetic nephropathy: main focus on the role of aldosterone Dan Med Bull 58 2011 B4265
20. N.J. Brown Aldosterone and vascular inflammation Hypertension 51 2008 161 167 (Pubitemid 351159920)
21. L.J. Min, M. Mogi, and J. Iwanami et al. Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence Cardiovasc Res 76 2007 506 516 (Pubitemid 350007454)
22. A.C. Montezano, G.E. Callera, and A. Yogi et al. Aldosterone and angiotensin II synergistically stimulate migration in vascular smooth muscle cells through c-Src-regulated redox-sensitive RhoA pathways Arterioscler Thromb Vasc Biol 28 2008 1511 1518
23. C.N. Merz, S.F. Kelsey, and C.J. Pepine et al. The Women's Ischemia Syndrome Evaluation (WISE) study: protocol design, methodology and feasibility report J Am Coll Cardiol 33 1999 1453 1461
24. B.L. Sharaf, C.J. Pepine, and R.A. Kerensky et al. Detailed angiographic analysis of women with suspected ischemic chest pain (pilot phase data from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation [WISE] Study Angiographic Core Laboratory) Am J Cardiol 87 2001 937 941 A3 (Pubitemid 32299974)
25. S.E. Reis, R. Holubkov, and J.S. Lee et al. Coronary flow velocity response to adenosine characterizes coronary microvascular function in women with chest pain and no obstructive coronary disease. Results from the pilot phase of the Women's Ischemia Syndrome Evaluation (WISE) study J Am Coll Cardiol 33 1999 1469 1475
26. J.A. Spertus, J.A. Winder, and T.A. Dewhurst et al. Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease J Am Coll Cardiol 25 1995 333 341
27. B. Pitt, F. Zannad, and W.J. Remme et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators N Engl J Med 341 1999 709 717 (Pubitemid 29407370)
28. S.J. Shah, J.F. Heitner, and N.K. Sweitzer et al. Baseline characteristics of patients in the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial Circ Heart Fail 6 2013 184 192
29. B. Pitt, W. Remme, and F. Zannad et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 348 2003 1309 1321 (Pubitemid 36384098)
30. F. Zannad, J.J. McMurray, and H. Krum et al. Eplerenone in patients with systolic heart failure and mild symptoms N Engl J Med 364 2011 11 21
31. J.K. Rogers, J.J. McMurray, and S.J. Pocock et al. Eplerenone in patients with systolic heart failure and mild symptoms: analysis of repeat hospitalizations Circulation 126 2012 2317 2323
32. W. Motz, and B.E. Strauer Improvement of coronary flow reserve after long-term therapy with enalapril Hypertension 27 1996 1031 1038 (Pubitemid 26140657)
33. D. Rizzoni, M.L. Muiesan, and E. Porteri et al. Effects of long-term antihypertensive treatment with lisinopril on resistance arteries in hypertensive patients with left ventricular hypertrophy J Hypertens 15 1997 197 204 (Pubitemid 27116503)
34. D. Giugliano, R. Marfella, and R. Acampora et al. Effects of perindopril and carvedilol on endothelium-dependent vascular functions in patients with diabetes and hypertension Diabetes Care 21 1998 631 636 (Pubitemid 28172947)
35. T. Higuchi, C. Abletshauser, and S.G. Nekolla et al. Effect of the angiotensin receptor blocker Valsartan on coronary microvascular flow reserve in moderately hypertensive patients with stable coronary artery disease Microcirculation 14 2007 805 812 (Pubitemid 350131388)
36. G.M. Rubanyi The discovery of endothelin: the power of bioassay and the role of serendipity in the discovery of endothelium-derived vasoactive substances Pharmacol Res 63 2011 448 454